Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix operating margin
Operating margin is operating income as a percentage of revenue.
Soligenix's operating margin for the twelve months ending Dec 31, 2024 was -7907.7%. For fiscal 2024 it was -7907.7%, against -917.1% the year before. The highest annual figure on record is -38.6% in fiscal 2011.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -7907.7% | −6990.6 |
| FY2023 | Dec 31, 2023 | -917.1% | +583.4 |
| FY2022 | Dec 31, 2022 | -1500.6% | +88.6 |
| FY2021 | Dec 31, 2021 | -1589.2% | −801.4 |
| FY2020 | Dec 31, 2020 | -787.7% | −560.1 |
| FY2019 | Dec 31, 2019 | -227.7% | −54.8 |
| FY2018 | Dec 31, 2018 | -172.8% | −33.0 |
| FY2017 | Dec 31, 2017 | -139.8% | −85.1 |
| FY2016 | Dec 31, 2016 | -54.6% | +26.4 |
| FY2015 | Dec 31, 2015 | -81.1% | +71.7 |
| FY2014 | Dec 31, 2014 | -152.8% | +69.2 |
| FY2013 | Dec 31, 2013 | -222.0% | −72.8 |
| FY2012 | Dec 31, 2012 | -149.2% | −110.5 |
| FY2011 | Dec 31, 2011 | -38.6% | +365.9 |
| FY2010 | Dec 31, 2010 | -404.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -74495.1% | −73707.2 |
| Q1 FY2024 | Mar 31, 2024 | -1809.0% | −972.8 |
| Q4 FY2023 | Dec 31, 2023 | -873.3% | +102.0 |
| Q3 FY2023 | Sep 30, 2023 | -1363.9% | +490.7 |
| Q2 FY2023 | Jun 30, 2023 | -787.9% | +697.1 |
| Q1 FY2023 | Mar 31, 2023 | -836.3% | +1393.0 |
| Q4 FY2022 | Dec 31, 2022 | -975.2% | +661.5 |
| Q3 FY2022 | Sep 30, 2022 | -1854.6% | −47.4 |
| Q2 FY2022 | Jun 30, 2022 | -1485.0% | −93.8 |
| Q1 FY2022 | Mar 31, 2022 | -2229.2% | −715.9 |
| Q4 FY2021 | Dec 31, 2021 | -1636.8% | +73.4 |
| Q3 FY2021 | Sep 30, 2021 | -1807.2% | −1509.4 |
| Q2 FY2021 | Jun 30, 2021 | -1391.2% | −834.3 |
| Q1 FY2021 | Mar 31, 2021 | -1513.4% | −596.8 |
| Q4 FY2020 | Dec 31, 2020 | -1710.2% | −1509.2 |
| Q3 FY2020 | Sep 30, 2020 | -297.8% | +13.3 |
| Q2 FY2020 | Jun 30, 2020 | -556.9% | −418.0 |
| Q1 FY2020 | Mar 31, 2020 | -916.5% | −824.4 |
| Q1 FY2019 | Mar 31, 2019 | -200.9% | +12.9 |
| Q4 FY2018 | Dec 31, 2018 | -311.1% | −111.7 |
| Q3 FY2018 | Sep 30, 2018 | -138.9% | −85.7 |
| Q2 FY2018 | Jun 30, 2018 | -92.1% | +141.7 |
| Q1 FY2018 | Mar 31, 2018 | -213.8% | −83.2 |
| Q4 FY2017 | Dec 31, 2017 | -199.4% | −123.1 |
| Q3 FY2017 | Sep 30, 2017 | -53.2% | −2.6 |
| Q2 FY2017 | Jun 30, 2017 | -233.8% | −201.8 |
| Q1 FY2017 | Mar 31, 2017 | -130.6% | −58.2 |
| Q4 FY2016 | Dec 31, 2016 | -76.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -50.6% | – |
| Q2 FY2016 | Jun 30, 2016 | -32.0% | – |
| Q1 FY2016 | Mar 31, 2016 | -72.4% | – |
See a number that looks wrong?